Treatment for decreased sperm motility on Semen analysis

Reading File

Finding Sources

Reading File

I now have comprehensive content from multiple urology and internal medicine textbooks. Let me compile a thorough, well-cited answer.

Treatment of Decreased Sperm Motility (Asthenozoospermia)

Overview

Decreased sperm motility on semen analysis is termed asthenozoospermia (progressive motility <30% or total motility <42% by WHO criteria). Management depends on identifying and treating the underlying cause wherever possible, with assisted reproductive technologies (ART) reserved for refractory or idiopathic cases.

1. Identify and Treat Underlying Causes (Specific Therapy)

Specific, cause-directed therapy is always preferred over empiric therapy.

A. Leukocytospermia (Genital Tract Infection/Inflammation)

Elevated leukocytes in semen generate reactive oxygen species (ROS — superoxide anions, hydrogen peroxide, hydroxyl radicals) that cause lipid peroxidation of sperm membranes, directly impairing motility.

Evaluate for STIs (chlamydia, gonorrhea, mycoplasma), prostatitis, epididymitis
Broad-spectrum antibiotics (e.g., doxycycline, trimethoprim-sulfamethoxazole) reduce seminal leukocyte concentrations
Frequent ejaculation (>every 3 days) combined with doxycycline gives more durable resolution than antibiotics alone
Antioxidants — vitamins A, C, E; glutathione; omega-3 fatty acids (fish oil) — scavenge ROS and improve motility in confirmed leukocytospermia

Smith and Tanagho's General Urology, 19th Edition

B. Antioxidant Therapy (Oxidative Stress)

Sperm are uniquely vulnerable to oxidative stress due to minimal cytoplasm and antioxidant capacity. Antioxidant supplementation with vitamins A, C, E, glutathione, and omega-3 fatty acids is used as both specific and empiric treatment to reduce membrane damage and improve motility.

Smith and Tanagho's General Urology, 19th Edition

C. Varicocele Repair

Varicocele is the most common correctable cause of male infertility. Varicocelectomy (surgical or radiologic) improves overall sperm parameters including motility and is recommended even when pregnancy is not guaranteed.

Goldman-Cecil Medicine

D. Hormonal Causes (Hypogonadotropic Hypogonadism)

1–2% of infertile men have gonadotropin insufficiency — this is the only group with a reliable pharmaceutical treatment
Gonadotropin therapy (FSH + hCG/LH) stimulates spermatogenesis and restores motility in men with pituitary/hypothalamic dysfunction
If elevated prolactin is identified: dopamine agonists (bromocriptine, cabergoline)

Goldman-Cecil Medicine

E. Immunologic Infertility (Antisperm Antibodies)

Corticosteroid immune suppression — reduces antibody levels but rarely used due to significant side effects
Sperm washing followed by intrauterine insemination (IUI)
IVF or ICSI — highly effective when antibodies are the primary issue

Smith and Tanagho's General Urology, 19th Edition

F. Retrograde Ejaculation

If retrograde ejaculation contributes to poor semen parameters:

Sympathomimetics: imipramine 25–50 mg twice daily, or pseudoephedrine (Sudafed Plus 60 mg three times daily), started several days before ejaculation; ~30% will respond with some antegrade ejaculation
Failure → sperm harvesting from post-ejaculate urine + IUI

Smith and Tanagho's General Urology, 19th Edition

G. Immotile Cilia Syndromes (Primary Ciliary Dyskinesia / Kartagener Syndrome)

Due to dynein arm defects in sperm axoneme
No treatment restores motility — sperm are viable but immotile
ICSI (intracytoplasmic sperm injection) is the treatment of choice, as it bypasses the need for motility entirely

Smith and Tanagho's General Urology, 19th Edition

2. Lifestyle and Coital Optimization

Gonadotoxin avoidance: heat (hot tubs, laptops on lap), tobacco, alcohol, anabolic steroids, recreational drugs, certain medications (sulfasalazine, chemotherapy)
Coital timing: intercourse every other day around ovulation (LH surge detection); sperm survive in cervical mucus for ~48 hours
Lubricants: most commercial lubricants are spermicidal — use vegetable oil, olive oil, or egg whites if needed

Smith and Tanagho's General Urology, 19th Edition

3. Empiric Therapies

Used when no specific cause is identified (idiopathic asthenozoospermia):

Agent	Rationale
Antioxidants (vit C, E, glutathione, CoQ10)	Reduce oxidative damage to sperm
Clomiphene citrate	Increases endogenous FSH/LH to stimulate spermatogenesis
FSH supplementation	Promotes sperm production
Carnitine supplementation	Supports sperm energy metabolism and motility

4. Assisted Reproductive Technologies (ART)

When motility is severely reduced or treatment fails:

Technique	Indication
IUI (Intrauterine Insemination)	Mild-moderate asthenozoospermia; requires ≥5 million motile sperm in ejaculate; pregnancy rate ~10–15%/cycle
IVF (In Vitro Fertilization)	Moderate-severe male factor; bypasses cervical transport
ICSI (Intracytoplasmic Sperm Injection)	Severe asthenozoospermia, immotile cilia, antibodies; directly injects single sperm into oocyte — theoretically bypasses all motility requirements

Smith and Tanagho's General Urology, 19th Edition; Berek & Novak's Gynecology; Harrison's Principles of Internal Medicine 22E

Key Takeaways

Always investigate the cause — treatable etiologies (varicocele, infection, hormonal, medications) should be corrected first
Mild–moderate asthenozoospermia: spontaneous pregnancy is possible; expectant management initially if female partner has no infertility factors
Antioxidants and lifestyle modification are appropriate for most patients regardless of cause
ICSI is the definitive ART option when motility is severely impaired or when other therapies fail, as it bypasses the need for sperm motility entirely

This is a shared conversation. Sign in to Orris to start your own chat.